SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-023057
Filing Date
2024-04-29
Accepted
2024-04-29 16:50:54
Documents
7
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20020522x1_def14a.htm DEF 14A 782306
2 logo_gritstonebiox2.jpg GRAPHIC 42509
3 ny20020522x1_pc01x1.jpg GRAPHIC 648637
4 ny20020522x1_pc02x1.jpg GRAPHIC 562135
5 ny20020522x1_pvpchart1.jpg GRAPHIC 95353
6 ny20020522x1_pvpchart2.jpg GRAPHIC 88399
7 sig_andrewallen.jpg GRAPHIC 14782
  Complete submission text file 0001140361-24-023057.txt   2781652
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38663 | Film No.: 24892069
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)